Track the Pharmanutra PHN stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares trade on the IT market, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra PHN has logged 12 reports. Market capitalisation: €784.2m. The latest transaction was disclosed on 8 September 2025 (Other). All data is openly available.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,333 of 28,752 companies
62.0
score / 100
Value
39
Quality
85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Pharmanutra PHN is a company specialized in the health and pharmaceutical sector, providing innovative products for well-being. It is listed on the XMIL market.